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Abstract The protective effect of vitamin D against several
cancers including colorectal cancer is modulated by the vita-
min D receptor (VDR) and its ligand, the active form of
vitamin D. VDR response has been found to play a role in
various genes encoding proteins involved in crucial cellular
pathways. Single nucleotide polymorphisms (SNPs) of the
VDR gene that modulate its activity are located in the pro-
moter region, exons 2–9, and their vicinity and also in the 3′
UTR region. Some of them have been previously studied in
relation to cancer susceptibility and prognosis. The aim of our
study was to investigate four polymorphisms, BsmI, ApaI,
TaqI, and FokI, of the VDR gene in Polish patients with
sporadic colorectal cancer and to evaluate their association
with susceptibility to cancer. We found a significant associa-
tion between the BsmI genotype and cancer (individuals with
the bb genotype are more susceptible to cancer compared to
those with other genotypes, p=0.025, Fisher’s exact test for
2×2 table). Also, the TT genotype at TaqI and the AA geno-
type at ApaI are correlated with a higher risk of cancer (p=
0.00071 and p=1.0×10−5, respectively). We found relatively
strong linkage disequilibrium between the TaqI and ApaI loci
(T with A and t with a, respectively). Both of these loci are
associated with cancer. We do not observe any such associa-
tion for the FokI polymorphism. In conclusion, a small mod-
ification in VDR expression may play a role in such a
multipathway process as tumorigenesis.
Keywords Colorectal cancer . VitaminD receptor . Gene
polymorphisms
Introduction
Vitamin D is described to have a protective effect against
several cancers including colorectal cancer, which is one of
the most common cancers in the world [1]. This effect is
modulated by the vitamin D receptor (VDR) and its ligand,
t h e ac t i v e f o rm o f v i t am in D—1α , 25 - (OH) 2 -
dihydroxyvitamin D (1,25(OH)2D3, calcitriol). 1,25(OH)2D3
is produced locally in many tissues and is the most active
natural metabolite of vitamin D [2]. VDR, an intracellular
hormone receptor, is expressed in normal colon epithelial cells
and other colon cells at various levels, and higher expression
correlates with epithelial differentiation and better prognosis,
while VDR downregulation is associated with poor prognosis
and cancer progression [3]. VDR is a transcriptional regulato-
ry factor that interacts with particular nucleotide sequences of
target genes and is encoded by a gene of over 100 kb with two
promoter regions, eight coding exons (from 2 to 9), and six
untranslated exons (1a–1f) [4]. VDR response plays a role in
various genes encoding proteins that act in, e.g., cellular
growth, apoptosis, differentiation, or metastasis [2]. Over 60
single nucleotide polymorphisms (SNPs) of the VDR gene
located in the promoter region, in exons 2–9, and their vicin-
ity, as well as in the 3′UTR region, that modulate its activity
have been described and some of them have been studied in
relation to cancer susceptibility and prognosis [1, 2]. A few of
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them are functional and affect expression of the VDR gene.
These include the FokI (rs10735810) polymorphism located
in the start codon, the major allele of which produces a protein
shorter by three amino acids, and the BsmI (rs1544410), ApaI
(rs7975232), and TaqI (rs731236) polymorphisms located in
the 3′UTR region, all involved in regulating the stability of
VDRmRNA [5]. The presence of the BAt haplotype (B allele
of BsmI, A allele of ApaI, and t allele of TaqI) is associated
with increased expression of VDR [5–7]. SNPs of the VDR
gene can influence the level, activity, and properties of the
gene transcription of proteins and therefore the biological
functioning of vitamin D [8].
The relationship between polymorphisms of the VDR gene
and sporadic colorectal cancer has been previously studied [4,
8].Meta-analysis of a large number of studies revealed that the
bb genotype at the BsmI polymorphism of the VDR gene is
associated with an increased risk of colon cancer, particularly
in the Asian population, although no association with other
polymorphisms has been reported [4, 8].
The aim of our study was to investigate four polymor-
phisms,BsmI, ApaI, TaqI, and FokI, of theVDR gene in Polish
patients with sporadic colorectal cancer and to evaluate their
association with the risk of cancer.
Materials and methods
One hundred seventy-nine sporadic colorectal cancers (CRCs)
obtained after surgery from the First Department of Surgical
Oncology at the Lower Silesian Oncology Centre in Wroclaw
were molecularly characterized, including analysis of the
BRAF V600E (exon 15) and K-ras (codon 12 and codon 13)
mutations, methylator phenotype (CIMP), and chromosomal
instability [9]. The mean age of patients was 65.7 with a
standard deviation of 11.2; the number of women was 73
(40.78 %) and the number of men was 106 (59.22 %). All of
them were diagnosed with adenocarcinoma coli. Biological
material was collected before chemo- and radiotherapy. All
the patients were interviewed in regard to their family history
of cancer, and those with hereditary cancer syndromes were
excluded from the study group. One hundred eighty healthy
individuals from the control group were matched according to
sex and age.
The study design was accepted by the Ethical Committee
of Wroclaw Medical University.
The analysis of the VDR gene polymorphisms, ApaI, Bsm-
I, FokI, and TaqI, was determined using SNaPshot reaction
according to the producer’s protocol (SNaPshotMultiplex Kit,
Applied Biosystems) [10] preceded by PCR with a 10x buffer
containing 15 mMMgCl2, 2 μl (Qiagen); dNTP (2 mM each,
Fermentas), 2 μl; TaqI polymerase (5 U/μl, Qiagen), 0.3 μl;
primers (10 mM), 1 μl; and H2O, 7.7 μl to a final volume of
18 μl. These primer sequences are described by Lins et al.
[11].
The following PCR and SNaPshot conditions were previ-
ously described [12].
Products were separated using an ABI 310 Genetic
Analyser with GeneScan Analysis version 3.1.2 software
(Applied Biosystems), POP-4 Polymer (Applied
Biosystems), and the LIZ 120 size standard (Applied
Biosystems) for 15 min. Analysis of the results was per-
formed using GeneMarker version 1.85 software
(SoftGenetics LLC).
Statistical analysis
The chi-squared goodness of fit test was used to investigate
the existence of linkage disequilibrium between the
rs10735810 (FokI), rs1544410 (BsmI), rs7975232 (ApaI),
and rs731236 (TaqI) VDR polymorphisms and whether the
genotype frequencies were in agreement with the Hardy-
Weinberg equilibrium. When analyzing linkage disequilib-
rium, an iterative gene counting procedure was used to
estimate the haplotype frequencies [13]. Fisher’s exact test
was used to analyze the association between the genotypes
are these loci and colorectal cancer. The CHAID procedure
for hierarchical analysis of these associations was also
applied [14].
Results
The patients were aged between 32 and 87, with a mean
age of 65.7 and a standard deviation of 112. It should be
noted that there are significantly more males in the study
group than females (binomial test, p=0.017), which may
indicate that males are more susceptible to colorectal
cancer.
The distribution of the genotypes at the ApaI and TaqI
polymorphisms is consistent with the H-W law in the
control group (ApaI p=0.1675, TaqI p=0.1344), but not
in the CRC group (ApaI p=0.0085, TaqI p=0.0230). The
FokI polymorphism does not show a significant deviation
from the Hardy-Weinberg equilibrium in either the control
of CRC group (p=0.8534 and p=0.5616, respectively).
The distribution of BsmI genotypes shows a very strong
deviation from the Hardy-Weinberg equilibrium, even in
the control group (p<10−5, see Table 1). We do not observe
any association between the FokI polymorphism and colo-
rectal cancer, and there is no linkage disequilibrium with
the other loci. There is relatively strong linkage disequilib-
rium between the TaqI and ApaI loci in both the study and
control groups. The T allele at TaqI is associated with the A
allele at ApaI. The t allele at TaqI is associated with the a
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allele at ApaI. Both of these loci are associated with cancer.
Those with the TT genotype at TaqI and the AA genotype
at ApaI are more susceptible to cancer than those with
other genotypes (p=0.0071 and p=10×10−5, respectively,
Fisher’s exact test for 2×2 table). There is a significant
association between the BsmI genotype and cancer. Those
with the bb genotype are more susceptible to cancer, p=
0.025 (see also Table 2).
Discussion
There is no doubt that the risk of sporadic colorectal cancer is
associated with such environmental factors as dietary habits,
lifestyle, and also genetic factors. It has also been revealed that
vitamin D intake and the level of 25-hydroxyvitamin D in
serum are inversely associated with colorectal cancer [4]. The
role of VDR in various cellular pathways suggests it plays a
Table 1 Hardy-Weinberg
equilibrium
Numbers in brackets give% value
*Significant difference from
Hardy-Weinberg equilibrium
Polymorphism Genotype Observed Expected Chi-square p value
Control group
rs731236 (TaqI) TT 57 (31.9 %) 52.0 (29.1 %) 2.24 0.1344
Tt 79 (44.1 %) 89.0 (49.7 %)
tt 43 (24.1 %) 38.0 (21.2 %)
rs7975232 (ApaI) AA 29 (15.4 %) 33.6 (17.9 %) 1.9 0.1675
Aa 101 (53.7 %) 91.8 (48.8 %)
aa 58 (30.9 %) 62.6 (33.3 %)
rs1544410 (BsmI) BB 86 (45.7 %) 71.6 (38.1 %) 19.82 0.0000*
Bb 60 (31.9 %) 88.9 (47.3 %)
bb 42 (22.3 %) 27.6 (14.7 %)
rs10735810 (FokI) FF 62 (33.0 %) 62.6 (33.3 %) 0.03 0.8534
Ff 93 (49.5 %) 91.8 (48.8 %)
ff 33 (17.6 %) 33.6 (17.9 %)
Study group
rs731236 (TaqI) TT 74 (47.2 %) 67.6 (43.1 %) 5.17 0.0230*
Tt 58 (36.9 %) 70.9 (45.1 %)
tt 25 (15.9 %) 18.6 (11.8 %)
rs7975232 (ApaI) AA 58 (37.4 %) 50.0 (32.2 %) 6.92 0.0085*
Aa 60 (38.7 %) 76.0 (49.1 %)
aa 37 (23.9 %) 29.0 (18.7 %)
rs1544410 (BsmI) BB 38 (41.3 %) 24.0 (26.1 %) 34.07 0.0000*
Bb 18 (19.6 %) 46.0 (50.0 %)
bb 36 (39.1 %) 22.0 (23.9 %)
rs10735810 (FokI) FF 47 (28.7 %) 48.8 (29.8 %) 0.34 0.5616
Ff 85 (51.8 %) 81.3 (49.6 %)
ff 32 (19.5 %) 33.8 (20.6 %)
Table 2 Frequencies of geno-
types of VDR polymorphisms in
sporadic CRC
n/d not determined
aOR of TT genotype with respect
to other genotypes
b OR of AAgenotypewith respect
to other genotypes
c OR of bb genotype with respect
to other genotypes
d Using Fisher’s exact test for as-
sociation for the 3×2 table
Polymorphism Genotype CRC Control Chi-square p valued OR 95 % CI
rs731236 (TaqI) TT 74 (47 %) 57 (33 %) 7.655 0.0220 1.84a 1.15–2.95
Tt 58 (37 %) 78 (44 %)
tt 25 (16 %) 40 (23 %)
rs7975232 (ApaI) AA 58 (37 %) 29 (16 %) 20.479 0.0000 3.14b 1.84–5.47
Aa 60 (39 %) 100 (55 %)
aa 37 (24 %) 53 (29 %)
rs1544410 (BsmI) BB 38 (41 %) 42 (46 %) 6.316 0.0411 2.13c 1.08–4.31
Bb 18 (20 %) 28 (31 %)
bb 36 (39 %) 21 (23 %)
rs10735810 (FokI) FF 47 (29 %) 60 (33 %) 0.866 0.6553 n/d n/d
Ff 85 (52 %) 91 (50 %)
ff 32 (19 %) 31 (17 %)
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crucial role in the etiology and development of cancer [15].
Many studies on VDR gene polymorphisms and sporadic
CRC have shown a reduced risk of CRC for patients with
the B allele of BsmI, f allele of FokI and A allele of ApaI, and t
allele of TaqI, which are associated with higher activity of the
vitamin D receptor, but the influence of SNPs on
cancerogenesis may be modified by many elements including
the environment, lifestyle, and many other genetic factors [2,
8, 16]. In our study, we found that the following genotypes are
associated with a higher risk of colorectal cancer: the bb (CC)
genotype at the BsmI locus, the TT (AA) genotype at TaqI,
and the AA (GG) genotype at ApaI. There is no statistical
evidence for any association with FokI (5′-end polymor-
phism). We observed relatively strong linkage disequilibrium
between the TaqI and ApaI loci in both the study and control
groups. The T allele at TaqI is associated with the A allele at
ApaI. The t allele at TaqI is associated with the a allele at ApaI.
When the association of the ApaI genotype to cancer is taken
into account, there is no significant association between the
TaqI genotype and cancer. However, when the association of
the TaqI genotype to cancer is taken into account, the associ-
ation between the ApaI genotype remains significant. This
suggests that the ApaI genotype is more important in modu-
lating an individual’s susceptibility to cancer, and the associ-
ation between the TaqI genotype and cancer may result from
the linkage disequilibrium between TaqI and ApaI.
We also found a significant association between the
BsmI genotype and cancer. Those with the bb genotype
are more susceptible to cancer. However, the association
between the BsmI locus and the TaqI locus is very odd. In
the control group, there is linkage disequilibrium of me-
dium strength between TaqI and BsmI. In the study group,
the degree of linkage disequilibrium is large. The data
indicate that among those whose BsmI genotype is bb
(high risk), those who also have genotype TT at TaqI
are clearly more susceptible to cancer. However, among
those whose BsmI genotype is not bb (lower risk), those
who have genotype TT at TaqI are clearly less susceptible
to cancer.
Results from various meta-analyses have clearly shown the
statistically significant association of the B allele of BsmI with
reduced sporadic CRC risk using both a dominant model
(BB+Bb versus bb) and recessive model (BB versus Bb+
bb) [2, 8]. Our results are in agreement with other studies
considering BsmI, which suggest that the B allele of the BsmI
polymorphism has a protective effect against cancerogenesis
in a variety of ethnical populations [8]. The BsmI polymor-
phism does not modify the amino acid sequence of proteins,
mRNA, or protein levels. However, it exhibits strong linkage
disequilibrium with other VDR SNPs, including ApaI and
TaqI. This suggests that the BsmI, ApaI, and TaqI polymor-
phisms have a significant influence on VDR expression or
mRNA processing [17].
Results obtained from many studies and observed in meta-
analyses are the most reliable and have the highest statistical
value. Numerous studies on different gene polymorphisms
have shown that SNPs should be examined and interpreted
in functional groups (e.g., groups of polymorphisms that
reduce or enhance an enzyme’s activity) [2, 8]. Although the
conclusions obtained are sometimes contradictory because of
differing features of various populations, ethnic differences,
and even differences between groups of patients, the accumu-
lation of data frommany published results is statistically more
valid and can detect genetic associations with higher accuracy,
while reducing the probability of false-negative results [4, 8,
18].
Conclusion
Even a small modification in VDR activity or ligand affinity
may play a crucial role in such a multipathway process as
tumorigenesis due to the significant engagement of VDR in
biological processes in cells and its role in homeostasis.
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